Table 3.

Cox proportional hazards models: associations with all cause 1-year and 3-year mortality in patients with acute myocardial infarction (n = 651)

Variable	Reference	1-year mortality			3-year mortality
		Hazard ratio	95% CI	p value	Hazard ratio	95% CI	p value
DEC (grade 2/3)	Grade 0/1	2.57	1.07–6.17	0.0347	1.48	0.94–2.34	0.0897
Gender (female)	Male	0.60	0.31–1.16	0.1301	0.71	0.47–1.08	0.1046
Age [years]		1.05	1.01–1.09	0.0242	1.03	1.01–1.06	0.0057
Diabetes mellitus (yes)	No	1.02	0.54–1.91	0.9632	1.05	0.70–1.56	0.8177
PAOD (yes)	No	1.90	0.98–3.67	0.0566	2.11	1.37–3.25	0.0007
History of stroke (yes)	No	1.56	0.75–3.23	0.2334	1.55	0.96–2.49	0.0717
Chronic kidney disease (yes)	No	1.19	0.57–2.46	0.6423	1.39	0.88–2.22	0.1628
Reinfarction (yes)	No	1.39	0.69 –2.83	0.3595	0.83	0.55–1.25	0.3784
Any recanalization therapy (yes)	No	0.34	0.15–0.76	0.0088	0.63	0.37–1.10	0.1046
LVEF < 50	≥ 50	2.27	1.16–4.42	0.0161	2.21	1.47–3.32	0.0002
1-VD	3-VD	0.64	0.25–1.65	0.3531	0.74	0.42–1.31	0.2965
2-VD	3-VD	1.28	0.64–2.58	0.4839	1.21	0.77–1.91	0.4107
VD: Others, missing	3-VD	1.12	0.38–3.23	0.8415	1.39	0.67–2.87	0.3735
CRP > 3 mg/dl	≤ 3 mg/l	4.02	2.18–7.41	< 0.0001	3.13	2.09–4.68	< 0.0001
CRP data missing	≤ 3 mg/l	1.29	0.38–4.40	0.6861	0.94	0.42–2.08	0.8768

CI confidence interval, DEC diagonal ear lobe crease, PAOD peripheral arterial occlusive disease, LVEF left ventricular ejection fraction, VD vessel disease, CRP c-reactive protein